BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20558460)

  • 1. Cardiac conditioning: a review of evolving strategies to reduce ischaemia-reperfusion injury.
    Kharbanda RK
    Heart; 2010 Aug; 96(15):1179-86. PubMed ID: 20558460
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolving story of "conditioning" to protect against acute myocardial ischaemia-reperfusion injury.
    Hausenloy DJ; Yellon DM
    Heart; 2007 Jun; 93(6):649-51. PubMed ID: 17502643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efforts to reduce myocardial infarct size--the next step.
    Braunwald E
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):349-53. PubMed ID: 21821538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac pre- and post-conditioning: implications in anesthesia?
    Pesonen E
    Acta Anaesthesiol Scand; 2010 Aug; 54(7):793-4. PubMed ID: 20649515
    [No Abstract]   [Full Text] [Related]  

  • 6. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcolemmal permeability changes during ischaemia and reperfusion: release of survival factors.
    Lochner A
    Cardiovasc Res; 2008 Sep; 79(4):545-6. PubMed ID: 18596058
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning.
    Skyschally A; Schulz R; Heusch G
    Herz; 2008 Mar; 33(2):88-100. PubMed ID: 18344027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial ischaemia/reperfusion injury and preconditioning: effects of hypercholesterolaemia/hyperlipidaemia.
    Ferdinandy P
    Br J Pharmacol; 2003 Jan; 138(2):283-5. PubMed ID: 12540517
    [No Abstract]   [Full Text] [Related]  

  • 10. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection.
    Shimizu M; Tropak M; Diaz RJ; Suto F; Surendra H; Kuzmin E; Li J; Gross G; Wilson GJ; Callahan J; Redington AN
    Clin Sci (Lond); 2009 Aug; 117(5):191-200. PubMed ID: 19175358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischaemia, reperfusion, pre-and post-conditioning: telling friend from foe.
    Bondke Persson A; Persson PB
    Acta Physiol (Oxf); 2012 Nov; 206(3):157-9. PubMed ID: 23017102
    [No Abstract]   [Full Text] [Related]  

  • 12. [Conditioning the heart in cardiac surgery].
    Deja MA; Malinowski M
    Kardiol Pol; 2011; 69 Suppl 3():80-4. PubMed ID: 22125208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.
    Hausenloy D; Wynne A; Duchen M; Yellon D
    Circulation; 2004 Apr; 109(14):1714-7. PubMed ID: 15066952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical perspectives on reperfusion injury in acute myocardial infarction.
    Bainey KR; Armstrong PW
    Am Heart J; 2014 May; 167(5):637-45. PubMed ID: 24766972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective signalling: Past, present and future.
    Jovanović A
    Eur J Pharmacol; 2018 Aug; 833():314-319. PubMed ID: 29935170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotection via activation of protein kinase C-delta depends on modulation of the reverse mode of the Na+/Ca2+ exchanger.
    Bouwman RA; Salic K; Padding FG; Eringa EC; van Beek-Harmsen BJ; Matsuda T; Baba A; Musters RJ; Paulus WJ; de Lange JJ; Boer C
    Circulation; 2006 Jul; 114(1 Suppl):I226-32. PubMed ID: 16820577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotection by volatile anesthetics.
    Bienengraeber MW; Weihrauch D; Kersten JR; Pagel PS; Warltier DC
    Vascul Pharmacol; 2005; 42(5-6):243-52. PubMed ID: 15922257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remote conditioning: the future of cardioprotection?
    Heusch G
    J Cardiovasc Med (Hagerstown); 2013 Mar; 14(3):176-9. PubMed ID: 23412365
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
    Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.